Skip to content
Free shipping on orders of $100+. Some exclusions apply.
Subscribe & Save 15% off Subcription Orders.
  • About Us
    About Us
    • Our Story
    • How We Work
    • People
    • Business Development
  • Science
    Science
    • Scientific Approach
    • Published Scientific Papers
  • Products
    Products
    • Metabolic Switch
      Metabolic Switch
      • Shop
      • User Guide
      • Recipes
      • FAQs
    • JuvYou Mobile App
    • Learn
      Learn
      • Ketosis & Metabolism
      • Healthy Aging & Lifestyle
      • Mind, Body & Fitness
      • Nutrition & Recipes
  • Pipeline
  • Entities
  • Investors
    Investors
    • Press Releases
    • In the News
    • Longevity - Coming of Age Conference
Log in
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • LinkedIn
Juvenescence LogoJuvenescence Logo
  • About Us
    • Our Story
    • How We Work
    • People
    • Business Development
  • Science
    • Scientific Approach
    • Published Scientific Papers
  • Products
    • Metabolic Switch
      • Shop
      • User Guide
      • Recipes
      • FAQs
    • JuvYou Mobile App
    • Learn
      • Ketosis & Metabolism
      • Healthy Aging & Lifestyle
      • Mind, Body & Fitness
      • Nutrition & Recipes
  • Pipeline
  • Entities
  • Investors
    • Press Releases
    • In the News
    • Longevity - Coming of Age Conference
Log in
Cart

Press Releases

  • All
  • AgeX
  • Chrysea Labs
  • Conference
  • Evgen Pharma
  • Juvenescence
  • LyGenesis
  • MDI Therapeutics
  • Napa Therapeutics
  • NetraMark Corp.
  • Relation Therapeutics
  • Selah Therapeutics
  • Souvien Therapeutics
  • The Buck Institute

Juvenescence CEO Dr Greg Bailey Set to Speak at Web Summit 2022

November 01, 2022

Biotech Leader to Provide Longevity Insights at Annual Conference  Ramsey, Isle of Man – November 1, 2022 – Juvenescence Limited (“Juvenescence”), a life sciences company developing therapies and consumer products...

Read more

Relation Therapeutics Receives $1.3M Grant From the Gates Foundation to Identify Covid-19 Therapeutic Candidates

September 01, 2020

Relation Therapeutics, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.

Read more

  • Contact Us
  • Privacy Notice
  • Terms of Service
  • Cookie Notice
  • Refund Policy
  • Offers & Promotions

Juvenescence Aging & Longevity News

Sign up for the latest thought leadership, insights and news about Juvenescence and the Aging & Longevity space.

Stay connected.

  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • LinkedIn
  • Follow us on social media!
© 2023, Juvenescence. Consult with your physician prior to use and for any advice regarding specific medical conditions. Information on this website is provided as general information only and not an endorsement or promotion of any particular therapy or product, including any product offered for sale on this website. These statements have not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, prevent or cure any disease.
  • Choosing a selection results in a full page refresh.